10X Capital Venture Acquisition Corp. III
VCXBDelisted Jul 26, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001848948
10X Capital Venture Acquisition Corp. III was delisted on Jul 26, 2024; its insiders filed their last Form 4 on Mar 11, 2022; 11 institutions reported holding it in 13F filings for Q2 2024, worth $21.4M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by 10X Capital Venture Acquisition Corp. III insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for 10X Capital Venture Acquisition Corp. III, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Weisburd David | COO & Head of Origination | – | Mar 11, 2022 | 0 |
| Thomas Hans | Chief Executive Officer | – | Mar 11, 2022 | 0 |
| 10X Capital SPAC Sponsor III LLC | Director, 10% Owner | – | Mar 11, 2022 | 0 |
| 10X Capital Advisors, LLC | 10% Owner | – | Mar 11, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.